Category list : Atrial fibrillation
Sort by: Newest first Oldest first A-Z Z-A
-
Forgotten patients: thousands left on risky anticoagulant combinations Subscription
Combinations of drugs involving anticoagulants are one of the most frequent causes of medicine-related hospital admissions, but pharmacists can help reduce the risk.
-
Pharmacists to identify AF patients at risk of stroke in £9m NHS England programme
Specialist pharmacists across 23 areas in England will help to identify patients with atrial fibrillation who are at risk of stroke and could benefit from medication, under a £9m programme announced by NHS England.
-
Depression linked to atrial fibrillation diagnosis Subscription
Depression is associated with an increased likelihood of atrial fibrillation diagnosis, according to a study published in the European Journal of Preventive Cardiology.
-
Sleep disruption linked to atrial fibrillation risk Subscription
Sleep disruption is an important risk factor for developing atrial fibrillation, study results show.
-
Pharmacists in a multidisciplinary atrial fibrillation clinic Subscription
Atrial fibrillation (AF) is the most common cardiac rhythm disturbance and increases in prevalence with advancing age. Each year, Tallaght University Hospital in Dublin assesses and admits over 400 patients with stroke and transient ischemic attack. AF is implicated as a causative factor in 33% of these cases. An AF-related stroke is more likely to be fatal, disabling and recurrent than a non-AF related stroke. The risk of AF-related stroke is greatly reduced, however, by early detection ...
-
Anticoagulant prescribing for AF patients with high stroke risk more than doubles
GP prescribing of anticoagulants for the treatment of patients with atrial fibrillation and a high risk of stroke more than doubled between 2000 and 2016, from 35.4% to 75.5%, according to research published in July 2018.
-
Uncertainty over anticoagulation risks and benefits in CKD patients with AF Subscription
The risk of both stroke and haemorrhage increases as chronic kidney disease progresses, which can complicate the decision on whether to begin anticoagulation in those with concomitant atrial fibrillation.
-
Primary-care overprescribing of rivaroxaban in patients without atrial fibrillation Subscription
There is a national prescribing trend for rivaroxaban (Xarelto; Bayer), one of four drugs known as direct oral anticoagulants (DOACs), and prescription is steadily rising. The drug has six licensed indications, with four different dosages and at least five possible durations of therapy, depending on the condition being treated. Anecdotal evidence suggests that some patients have inadvertently remained on rivaroxaban in the long term in cases where the drug had been indicated for only ...
-
Anticoagulants could cut the risk of dementia for patients with atrial fibrillation, researchers find
Oral anticoagulants are associated with a significant reduction in the risk of dementia in patients with atrial fibrillation (AF), according to a study published in the European Heart Journal.
-
Pharmacists screening for AF in hi-tech partnership
Pharmacists are to use hand-held devices to test patients for atrial fibrillation (AF) as part of a hi-tech partnership in London.
Show 10 per page20 per page50 per page
